51
|
Martini G, Belli V, Vitiello P, Troiani T, Cardone C, Napolitano S, Desiderio V, Sforza V, Ferrara M, Papaccio G, Mele L, Liguori G, Botti G, Franco R, Morgillo F, Ciardiello F, Martinelli E. blockade overcomes primary and acquired resistance to anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer (mCRC). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw362.01] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
52
|
Vitiello P, Martini G, Belli V, Cardone C, Sforza V, Ferrara M, Napolitano S, Della Corte C, Zanaletti N, Vitale P, Pompella L, Morgillo F, Troiani T, Ciardiello F, Martinelli E. HER2 activation and epithelial-mesenchymal transition (EMT) are involved in the acquired resistance to cetuximab in combination with either regorafenib or refametinib. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw362.15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
53
|
Cardone C, Sforza V, Nappi A, Capasso A, Ferrara M, Martini G, Napolitano S, Vitiello P, Vitale P, Zanaletti N, Diadema M, Orditura M, De Vita F, Troiani T, Ciardiello F, Martinelli E. Outcomes of elderly chemorefractory metastatic colorectal (mCRC) patients (pts) treated with regorafenib: a single institution experience. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw335.31] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
54
|
Sforza V, Capasso A, Nappi A, Cardone C, Martini G, Ferrara M, Napolitano S, Vitiello P, Vitale P, Zanaletti N, De Vita F, Orditura M, Troiani T, Ciardiello F, Martinelli E. Outcomes of long responders chemorefractory metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib: a single institution experience. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw335.37] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
55
|
Troiani T, Sforza V, Cardone C, Nappi A, Capasso A, Martini G, Napolitano S, Zanaletti N, Vitale P, Vitiello P, De Vita F, Orditura M, Ferrara M, Ciardiello F, Martinelli E. Prevention of regorafenib related skin toxicity in refractory metastatic colorectal cancer (mCRC) patients (pts): a single institution experience. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw335.45] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
56
|
Pluchinotta FR, Schiavo B, Vittadello F, Martini G, Perilongo G, Zulian F. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes. Lupus 2016; 16:550-5. [PMID: 17711887 DOI: 10.1177/0961203307080636] [Citation(s) in RCA: 84] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
It is estimated that around 20% of patients with systemic lupus erythematosus (SLE) have their onset in childhood but there have been conflicting data about the prevalence and severity of the clinical features in different age classes. We conducted this study to analyse the clinical features of patients with pediatric SLE (pSLE) with onset in infancy, prepubertal and postpubertal age.The charts of patients followed at the Department of Pediatrics, University of Padua, who met the criteria for SLE diagnosis, were reviewed. Patients were divided into three groups based on age at disease onset: group A, patients ≤2 years old, group B patients aged between 2 and 10 years, group C patients between 11 and 16 years of age. The clinical and laboratory characteristics of each group were compared. Forty-two patients with pSLE entered the study: 2 were diagnosed before the age of 2 years, 11 between 2 and 10 years and 29 between 10 and 16 years. Eleven more patients with infantile (onset <2 years) SLE (iSLE) were found by a systematic literature search on PubMed and EmBASE and added for analysis to the group A. The female preponderance was significant only in postpubertal patients (F:M = 6.3: 1) whereas the other two groups presented a similar F:M ratio (1.2: 1). In comparison with the other two groups, iSLE showed a significantly higher prevalence of cardiovascular and pulmonary involvement, anemia and thrombocytopenia and a shorter disease duration at time of diagnosis. The postpubertal group showed a higher frequency of musculoskeletal involvement and leukopenia. In prepubertal patients there was no female preponderance and the frequency of clinical features was intermediate between infantile and postpubertal patients. Complement fractions level, antinuclear antibodies (ANA), anti-dsDNA, anti-cardiolipin antibodies and lupus anti-coagulant autoantibodies were not significantly different in the three groups. In general, the prevalence of internal organs involvement in pSLE seems to decrease with age. In infants, SLE is more severe than in the following ages. Postpubertal patients have a strong female preponderance and more specific signs of disease at onset. Prepubertal patients have an intermediate disease severity and no gender predilection. Lupus (2007) 16, 550—555.
Collapse
|
57
|
Romano DG, Cioni S, Leonini S, Gennari P, Vallone IM, Zandonella A, Puliti A, Tassi R, Casasco A, Martini G, Bracco S. Manual thromboaspiration technique as a first approach for endovascular stroke treatment: A single-center experience. Interv Neuroradiol 2016; 22:529-34. [PMID: 27301390 DOI: 10.1177/1591019916653256] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2016] [Accepted: 05/15/2016] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND For intracranial large vessel occlusion in acute ischemic stroke (AIS), a high degree of revascularization in the minimal amount of time predicts good outcomes. Recently, different studies have shown that the direct aspiration first pass technique (ADAPT technique) for AIS obtains high recanalization rates, fast interventions and low costs when it works as first attempt. This study retrospectively describes revascularization efficacy, duration of procedure, intra and post-procedural complications, early and after 90-days clinical outcome in a group of patients who underwent ADAPT as the primary endovascular approach, eventually followed by stent retriever thrombectomy, for recanalization of large vessels in the anterior circulation. MATERIALS AND METHODS We analyzed clinical and procedural data of patients treated from April 2014 to August 2015. Recanalization was assessed according to the Thrombolysis in Cerebral Infarction score. Clinical outcome was evaluated at discharge and after 3 months (modified Rankin Scale, mRS). RESULTS Overall, 71 patients (mean age of 69.7 years) were treated. Sites of occlusion were anterior circulation (including seven tandem extracranial-intracranial occlusions). In 39 patients i.v. rtPA was attempted. Recanalization of the target vessel was obtained in 87.3% of cases whereas direct aspiration alone was successful in 46/71cases (64.8%) with an average puncture-to-revascularization time of 43.1 minutes. Symptomatic intracranial hemorrhage occurred in 7.8% and embolization to new territories in 5.6%. In total, 38 patients (53.5%) had a good outcome at 90 days follow-up. CONCLUSIONS In our series, the manual thromboaspiration technique has been shown as fast and safe, with good rates of vessel revascularization in 87.3% of patients and neurological outcome <3 mRS in 53.5% of patients.
Collapse
|
58
|
Martinelli E, Troiani T, Venturini F, Cervantes Rupierez A, Douillard J, Falcone A, Folprecht G, Kohne C, Taieb J, Tabernero J, Cardone C, Sforza V, Martini G, Napolitano S, Capuano A, Auricchio F, Ciardiello F. Phase III study of regorafenib versus placebo as maintenance therapy in RAS wild type metastatic colorectal cancer (RAVELLO trial). Ann Oncol 2015. [DOI: 10.1093/annonc/mdv340.46] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
59
|
Ferrari D, Zannin M, Gerloni V, Pontikaki I, Bracaglia C, Cimaz R, Simonini G, Falcini F, Corona F, Viola S, Breda L, La Torre F, Vittadello F, Martini G, Zulian F. OP0066 Safety of Anti-TNFα Agents for the Treatment of Juvenile Idiopathic Arthritis-Related Uveitis: Data from the Orchidea Registry. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4559] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
60
|
Cappella M, Culpo R, Sprocati M, Meneghel A, Zulian F, Martini G. OP0307 Infrared Thermography After Cold Challenge: Validation in Diagnosis of Raynaud's Phenomenon in Pediatric Age. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4249] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
61
|
Martinelli E, Troiani T, Venturini F, Cervantes A, Douillard JY, Falcone A, Folprecht G, Kohne CH, Taieb J, Tabernero J, Cardone C, Sforza V, Martini G, Stefania N, Capuano A, Auricchio F, Ciardiello F. P-308 RAVELLO trial: Phase III study of regorafenib versus placebo as maintenance therapy in RAS wild type metastatic colorectal cancer. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv233.305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
62
|
Cecchin V, Balzarin M, Vittadello F, Meneghel A, Martini G, Zulian F. AB1027 Long-Term outcome of Oligoarticular Juvenile Idiopathic Arthritis: A Single Center Study. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.5085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
63
|
Marengoni A, Pasina L, Concoreggi C, Martini G, Brognoli F, Nobili A, Onder G, Bettoni D. Understanding adverse drug reactions in older adults through drug-drug interactions. Eur J Intern Med 2014; 25:843-6. [PMID: 25312593 DOI: 10.1016/j.ejim.2014.10.001] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/28/2014] [Revised: 09/29/2014] [Accepted: 10/01/2014] [Indexed: 01/01/2023]
Abstract
AIMS The aims of this study are to evaluate prevalence and characteristics of adverse drug reactions (ADRs) and to evaluate the potential contribution of specific medications, therapeutic categories and drug-drug interactions (DDIs) in older adults. METHODS All ADR reporting forms of persons aged 65+ years collected by the pharmacovigilance of one of the main hospitals in Italy during 2013 were evaluated. DDIs were analysed by a computerized prescription system (INTERCheck) and based on the interactions' database managed by the Istituto di Ricerche Farmacologiche Mario Negri. DDIs were classified according to their clinical relevance as contraindicated, major, and moderate. RESULTS Amongst all the ADR reporting forms (n=1014) collected during 2013, 343 affected older adults. The most frequent ADRs were: haemorrhages (n=122, 35.5%), allergic reactions (n=56, 16.3%), and elevated International Normalized Ratio (INR>6, n=54, 15.7%). The specific medications that contributed to ADRs were warfarin (42.5%), acenocumarol (9%), and allopurinol (8.5%); while the therapeutic categories were haematological agents (67%) and proton pump inhibitors (13%). A total of 912 DDIs were found; one third of them were contraindicated or major and 31.5% of them potentially contributed to ADRs; of these, the most frequent were: warfarin and heparin (contraindicated, n=5); warfarin and a statin (major, n=38); warfarin and a proton pump inhibitor (moderate, n=40). At least one DDI contributed to 66 haemorrhages out of 122 (54%) and to 41 elevated INR out of 54 (76%). CONCLUSION DDIs significantly contribute to the onset of ADRs in older adults and intervention programmes, e.g., the employment of a computerized system, may reduce the burden of iatrogenic illnesses in the elderly.
Collapse
|
64
|
Troiani T, Napolitano S, Martinelli E, Vitagliano D, Martini G, Morgillo F, Cardone C, Capasso A, Gambardella V, Venturini F, Ciardiello F. Optimal Strategy with Multi-Targeted Therapies in Egfr-Dependent “Quadruple Wild Type (Wt) for Kras, Braf, Nras and Pik3Ca Genes” Colorectal Cancer (Crc) Xenografts After Combined Treatment of Irinotecan Plus Cetuximab. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu358.10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
65
|
Capasso A, Gambardella V, Martinelli E, Troiani T, Nappi A, Sforza V, Manzo A, Martini G, Della Corte C, Napolitano S, Laterza M, Morgillo F, Vitagliano D, Orditura M, De Vita F, Ciardiello F. Cell Growth Inhibition of Her2 Positive Trastuzumab Resistant Gastric Cancer Cell Lines By Combined Inhibition of Pi3K/Akt/Mtor and Mapk. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu334.28] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
66
|
Martini G, Troiani T, Vitagliano D, Napolitano S, Morgillo F, Liotti F, Melillo R, Vitiello P, Capasso A, Gambardella V, Ciardiello D, Venturini F, Cardone C, Orditura M, Ciardiello F, Martinelli E. Axl Tyrosine Kinase Receptor As a Key Regulator of Proliferation and Survival in Colorectal Cancer (Crc). Ann Oncol 2014. [DOI: 10.1093/annonc/mdu358.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
67
|
Napolitano S, Martinelli E, Vitagliano D, Martini G, Cardone C, De Vita F, Ciardiello F, Troiani T. Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-Egfr Antibodies Can Be Overcome By the Treatment with Regorafenib in Combination with Cetuximab. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu358.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
68
|
Cardone C, Liguori G, Troiani T, Nappi A, Amoroso N, Iaffaioli V, Romano C, Botti G, Vitagliano D, Martini G, Napolitano S, Morgillo F, Sforza V, Giunta E, Di Maio M, De Vita F, Ciardiello F, Martinelli E. Expression of Axl Receptor and Its Ligand Gas6 in Colorectal Cancer (Crc). Ann Oncol 2014. [DOI: 10.1093/annonc/mdu326.49] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
69
|
Minardo G, Carraro V, Martini G, Murer L, Vittadello F, Schiavon F, Zulian F. PReS-FINAL-2360: Severe disease course of pediatric-onset granulomatosis with polyangiitis as compared to adult patients: a long-term, single center, follow up study. Pediatr Rheumatol Online J 2013. [PMCID: PMC4044114 DOI: 10.1186/1546-0096-11-s2-p350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
70
|
Culpo R, Ricca M, Vittadello F, Sequi G, Zulian F, Martini G. PReS-FINAL-2128: Quality of life and psychosocial aspects in juvenile localized scleroderma (JLS): a cross-sectional study in 40 patients. Pediatr Rheumatol Online J 2013. [PMCID: PMC4043758 DOI: 10.1186/1546-0096-11-s2-p140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
71
|
Varenna M, Bertoldo F, Di Monaco M, Giusti A, Martini G, Rossini M, SIOMMMS OBO, SIR EB. Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature. Reumatismo 2013; 65:143-66. [DOI: 10.4081/reumatismo.2013.143] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2013] [Revised: 10/14/2013] [Accepted: 10/15/2013] [Indexed: 11/23/2022] Open
|
72
|
Minardo G, Carraro V, Martini G, Murer L, Vittadello F, Schiavon F, Zulian F. AB0682 Severe disease course of pediatric granulomatosis with polyangiitis as compared to adult patients: a long-term, single center, follow up study. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.3004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
73
|
Falcini F, Denaro V, Cuoco F, Martini G, Cappelli S, Petaccia A, Corona F, Carnesecchi G, La Torre F, Matucci Cerinic M, Rigante D. THU0306 Predictors of outcome in a cohort of italian children/adolescents with primary raynaud’s phenomenon: A multicenter study. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
74
|
Brachi S, De Somer L, Lambot K, Martini G, Bader-Meunier B, Zulian F, Wouters C. SAT0483 Dry Synovitis: A Unique Entity? A Multicenter Study. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
75
|
Zanon G, Corradin S, Martini G, Vittadello F, Zulian F. THU0313 Is MRI a reliable tool for monitoring chronic non bacterial osteomyelitis?:. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|